| Cardiovascular prevention in women: a narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' |
17 |
| Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications |
16 |
| Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve |
13 |
| Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample |
12 |
| The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport |
11 |
| Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE |
8 |
| Effects of postprandial hydroxytyrosol and derivates on oxidation of LDL, cardiometabolic state and gene expression: a nutrigenomic approach for cardiovascular prevention |
8 |
| Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study |
7 |
| Cryoballoon vs. radiofrequency contact force ablation for paroxysmal atrial fibrillation: a propensity score analysis |
6 |
| A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy |
6 |
| Unresolved issues in left ventricular postischemic remodeling and progression to heart failure |
6 |
| Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) |
5 |
| Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) |
5 |
| Gender differences in cardiology: is it time for new guidelines? |
5 |
| Cardiovascular interventions planning through a three-dimensional printing patient-specific approach |
5 |
| Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study |
5 |
| Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome |
5 |
| Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation |
5 |
| Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases |
4 |
| Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention |
4 |
| Sex-specific echocardiographic reference values: the women's point of view |
4 |
| ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance |
4 |
| Type 2 myocardial infarction: a grim diagnosis with different shades of gray |
4 |
| Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention |
4 |
| Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: a systematic review of the literature |
4 |
| Long-term progression of rhythm and conduction disturbances in pacemaker recipients: findings from the Pacemaker Expert Programming study |
4 |
| Is the time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation a predictor of efficacy? |
4 |
| Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection |
4 |
| Neuro-arrhythmology: a challenging field of action and research: a review from the Task Force of Neuro-arrhythmology of Italian Association of Arrhythmias and Cardiac Pacing |
4 |
| Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses |
4 |
| Comparison of cryoballoon and radiofrequency ablation techniques for atrial fibrillation: a meta-analysis |
4 |
| Evolution of the pericardiocentesis technique |
4 |
| Vitamin D, parathyroid hormone and cardiovascular risk: the good, the bad and the ugly |
4 |
| Left atrial volume index is critical for the diagnosis of heart failure with preserved ejection fraction |
4 |
| Quantification of acute parasympathetic denervation during cryoballoon ablation by using extracardiac vagal stimulation |
4 |
| Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial |
4 |
| Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery |
3 |
| Intracoronary versus intravenous adenosine to assess fractional flow reserve: a systematic review and meta-analysis |
3 |
| Evidence of impaired longitudinal strain in pre-Fontan palliation in functional single left ventricle |
3 |
| Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience |
3 |
| Diagnostic power and healthcare resource consumption of a dedicated workflow algorithm designed to manage thoracic impedance alerts in heart failure patients by remote monitoring |
3 |
| Clinical profile of patients with heart failure can predict rehospitalization and quality of life |
3 |
| Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study) |
3 |
| Atrial conduit function quantitation precardioversion predicts early arrhythmia recurrence in persistent atrial fibrillation patients |
3 |
| Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature |
3 |
| Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach |
3 |
| Insertable cardiac monitor detection of silent atrial fibrillation in candidates for percutaneous patent foramen ovale closure |
3 |
| Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis |
3 |
| Is pericardial effusion a negative prognostic marker? Meta-analysis of outcomes of pericardial effusion |
3 |
| Nonvalvular atrial fibrillation in high-hemorrhagic-risk patients: state of the art of percutaneous left atrial appendage occlusion |
3 |
